Guru Ownership Trend
Guru Analysis for Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $29.26 M.
Top institutional holders include Ken Fisher and Paul Tudor Jones.
Institutional sentiment is currently Bearish. This is evidenced by a $106.97 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Crinetics Pharmaceuticals, Inc. (CRNX)
Major holders include Ken Fisher ($27.7 M), Paul Tudor Jones ($1.67 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 808,723 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $106.97 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited CRNX. The total reported sell value was $108.79 M.
Yes, 1 managers opened new positions in CRNX, and 1 increased their existing holdings. The total reported buy value was $1.82 M.